<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Our data show that: Most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells express significantly less HLA class I and II than the corresponding LCLs </plain></SENT>
<SENT sid="1" pm="."><plain>Lymphoblastoid cell lines have a much higher HLA class I and II density than <z:mpath ids='MPATH_458'>normal</z:mpath> peripheral blood B cells </plain></SENT>
<SENT sid="2" pm="."><plain>There are qualitative differences in class I and II expression in most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>/LCL pairs </plain></SENT>
<SENT sid="3" pm="."><plain>These qualitative differences are not caused by <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>They might be due to a selective downregulation of HLA specifities by c-myc activation </plain></SENT>
<SENT sid="5" pm="."><plain>We conclude that these modifications of HLA expression may well play a role in the reduced specific immune recognition of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells </plain></SENT>
</text></document>